Difficulty: Medium
Average Score: 82%
Practice
Iron chelating agents are used for treatment of:
Correct answer
D
Rationale
Iron chelating agents are used for the treatment of chronic hemolytic anemia because this condition is characterized by increased breakdown of red blood cells, leading to the release of excess iron into the bloodstream. Iron chelators bind to this excess iron and help remove it from the body, preventing iron overload and associated complications.
Option A, leukemia, is incorrect because iron chelating agents are not typically used in the treatment of leukemia. Leukemia is a cancer of the blood and bone marrow, and its treatment involves chemotherapy, radiation therapy, and sometimes stem cell transplants.
Option B, lymphoma, is also incorrect as iron chelators are not a standard part of lymphoma treatment. Lymphoma is a type of cancer that affects the lymphatic system, and treatment typically involves chemotherapy, immunotherapy, radiation therapy, or a combination of these.
Option C, Wilms tumor, is incorrect because iron chelating agents are not indicated for the treatment of this specific type of kidney cancer that primarily affects children. Treatment for Wilms tumor usually involves surgery, chemotherapy, and sometimes radiation therapy.
In an educational context, understanding the appropriate use of iron chelating agents in chronic hemolytic anemia is crucial for pediatric nurses caring for children with this condition. This knowledge helps nurses provide safe and effective care, monitor for potential side effects of iron chelators, and educate patients and families on the importance of treatment compliance.
Option A, leukemia, is incorrect because iron chelating agents are not typically used in the treatment of leukemia. Leukemia is a cancer of the blood and bone marrow, and its treatment involves chemotherapy, radiation therapy, and sometimes stem cell transplants.
Option B, lymphoma, is also incorrect as iron chelators are not a standard part of lymphoma treatment. Lymphoma is a type of cancer that affects the lymphatic system, and treatment typically involves chemotherapy, immunotherapy, radiation therapy, or a combination of these.
Option C, Wilms tumor, is incorrect because iron chelating agents are not indicated for the treatment of this specific type of kidney cancer that primarily affects children. Treatment for Wilms tumor usually involves surgery, chemotherapy, and sometimes radiation therapy.
In an educational context, understanding the appropriate use of iron chelating agents in chronic hemolytic anemia is crucial for pediatric nurses caring for children with this condition. This knowledge helps nurses provide safe and effective care, monitor for potential side effects of iron chelators, and educate patients and families on the importance of treatment compliance.